Clinical Trial Update: Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a risk-factor–tailored therapy approach for adults ≤60 with acute myeloid leukemia. The document provides no results or curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: dr hab. n. med. Agnieszka Wierzbowska | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: UNKNOWN